TARE in Hepatocellular Carcinoma: From the Right to the Left of BCLC

被引：40

作者：

Guiu, Boris ^{[1
]}

Garin, Etienne ^{[2
]}

Allimant, Carole ^{[1
]}

Edeline, Julien ^{[3
]}

Salem, Riad ^{[4
]}

机构：

[1] St Eloi Univ Hosp, Dept Radiol, 80 Ave Augustin Fliche, F-34295 Montpellier, France

[2] Ctr Lutte Canc Eugene Marquis, Dept Nucl Med, F-35000 Rennes, France

[3] Ctr Lutte Canc Eugene Marquis, Dept Oncol, F-35000 Rennes, France

[4] Northwestern Univ, Dept Radiol, Sect Intervent Radiol, Chicago, IL 60611 USA

来源：

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY | 2022年 / 45卷 / 11期

关键词：

Liver cancer; Radioembolization; Yttrium; Dosimetry; INTERNAL RADIATION-THERAPY; PORTAL-VEIN EMBOLIZATION; Y-90 GLASS MICROSPHERES; LIVER-CANCER; RADIOEMBOLIZATION; CHEMOEMBOLIZATION; SURVIVAL; SORAFENIB; DOSIMETRY; EFFICACY;

D O I：

10.1007/s00270-022-03072-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The Barcelona Clinic Liver Cancer (BCLC) system is the most commonly used staging system for hepatocellular carcinoma (HCC) in Western countries. BCLC aims to categorize patients into five stages with different prognoses and to allocate treatment according to these stages based on the best possible contemporary evidence. Transarterial radioembolization (TARE) has recently entered at the left of the BCLC algorithm (i.e., BCLC 0-A), mainly because of negative phase III trials in BCLC C stage. TARE has shown a steady increase in nationwide studies over the past 20 years and has even been adopted in some tertiary centers as the primary HCC treatment across all BCLC stages. We aimed to review the history of TARE in HCC, starting from advanced HCC and gradually expanding to earlier stages at the left of the BCLC system.

引用

页码：1599 / 1607

页数：9

共 69 条

[1] Hepatobiliary Scintigraphy and Glass 90Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated Liver [J].

Allimant, Carole ;

Deshayes, Emmanuel ;

Kafrouni, Marilyne ;

Santoro, Lore ;

de Verbizier, Delphine ;

Fourcade, Marjolaine ;

Cassinotto, Christophe ;

Hermida, Margaux ;

Guillot, Chloe ;

Mariano-Goulart, Denis ;

Guiu, Boris .

DIAGNOSTICS, 2021, 11 (06)

[2] Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma [J].

Allimant, Carole ;

Kafrouni, Marilyne ;

Delicque, Julien ;

Ilonca, Diana ;

Cassinotto, Christophe ;

Assenat, Eric ;

Ursic-Bedoya, Jose ;

Pageaux, Georges-Philippe ;

Mariano-Goulart, Denis ;

Aho, Serge ;

Guiu, Boris .

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 29 (12) :1662-1670

[3] TREATMENT OF INOPERABLE PRIMARY PANCREATIC AND LIVER CANCER BY INTRA-ARTERIAL ADMINISTRATION OF RADIOACTIVE ISOTOPES (Y99 RADIATING MICROSPHERES) [J].

ARIEL, IM .

ANNALS OF SURGERY, 1965, 162 (02) :267-&

[4] A comparative study of portal vein embolization versus radiation lobectomy with Yttrium-90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma [J].

Bekki, Yuki ;

Marti, Josep ;

Toshima, Takeo ;

Lewis, Sara ;

Kamath, Amita ;

Argiriadi, Pamela ;

Simpson, William ;

Facciuto, Lucas ;

Patel, Rahul S. ;

Gunasekaran, Ganesh ;

Kim, Edward ;

Schiano, Thomas D. ;

Facciuto, Marcelo E. .

SURGERY, 2021, 169 (05) :1044-1051

[5] Radiation Segmentectomy versus Selective Chemoembolization in the Treatment of Early-Stage Hepatocellular Carcinoma [J].

Biederman, Derek M. ;

Titano, Joseph J. ;

Korff, Ricki A. ;

Fischman, Aaron M. ;

Patel, Rahul S. ;

Nowakowski, Francis S. ;

Lookstein, Robert A. ;

Kim, Edward .

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 29 (01) :30-37

[6] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial [J].

Bruix, Jordi ;

Raoul, Jean-Luc ;

Sherman, Morris ;

Mazzaferro, Vincenzo ;

Bolondi, Luigi ;

Craxi, Antonio ;

Galle, Peter R. ;

Santoro, Armando ;

Beaugrand, Michel ;

Sangiovanni, Angelo ;

Porta, Camillo ;

Gerken, Guido ;

Marrero, Jorge A. ;

Nadel, Andrea ;

Shan, Michael ;

Moscovici, Marius ;

Voliotis, Dimitris ;

Llovet, Josep M. .

JOURNAL OF HEPATOLOGY, 2012, 57 (04) :821-829

[7] Ablative Transarterial Radioembolization Improves Survival in Patients with HCC and Portal Vein Tumor Thrombus [J].

Cardarelli-Leite, Leandro ;

Chung, John ;

Klass, Darren ;

Marquez, Vladimir ;

Chou, Frank ;

Ho, Stephen ;

Walton, Henry ;

Lim, Howard ;

Tae Wan Kim, Peter ;

Hadjivassiliou, Anastasia ;

Liu, David M. .

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 43 (03) :411-422

[8] Changing trends in hepatocellular carcinoma management: Results from a nationwide database in the last decade [J].

Cassinotto, Christophe ;

Nogue, Erika ;

Morell, Mathieu ;

Panaro, Fabrizio ;

Molinari, Nicolas ;

Guiu, Boris .

EUROPEAN JOURNAL OF CANCER, 2021, 146 :48-55

[9] SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma [J].

Chow, Pierce K. H. ;

Gandhi, Mihir ;

Tan, Say-Beng ;

Khin, Maung Win ;

Khasbazar, Ariunaa ;

Ong, Janus ;

Choo, Su Pin ;

Cheow, Peng Chung ;

Chotipanich, Chanisa ;

Lim, Kieron ;

Lesmana, Laurentius A. ;

Manuaba, Tjakra W. ;

Yoong, Boon Koon ;

Raj, Aloysius ;

Law, Chiong Soon ;

Cua, Ian H. Y. ;

Lobo, Rolley R. ;

Teh, Catherine S. C. ;

Kim, Yun Hwan ;

Jong, Yun Won ;

Han, Ho-Seong ;

Bae, Si-Hyun ;

Yoon, Hyun-Ki ;

Lee, Rheun-Chuan ;

Hung, Chien-Fu ;

Peng, Cheng-Yuan ;

Liang, Po-Chin ;

Bartlett, Adam ;

Kok, Kenneth Y. Y. ;

Thng, Choon-Hua ;

Low, Albert Su-Chong ;

Goh, Anthony S. W. ;

Tay, Kiang Hiong ;

Lo, Richard H. G. ;

Goh, Brian K. P. ;

Ng, David C. E. ;

Lekurwale, Ganesh ;

Liew, Wei Ming ;

Gebski, Val ;

Mak, Kenneth S. W. ;

Soo, Khee Chee .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) :1913-+

[10] Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials [J].

Di Federico, Alessandro ;

Rizzo, Alessandro ;

Carloni, Riccardo ;

De Giglio, Andrea ;

Bruno, Riccardo ;

Ricci, Dalia ;

Brandi, Giovanni .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (04) :361-369

← 1 2 3 4 5 6 7 →